...
首页> 外文期刊>The Journal of heart valve disease >Cardiac valve replacement with mechanical prostheses in patients aged 65 years and over.
【24h】

Cardiac valve replacement with mechanical prostheses in patients aged 65 years and over.

机译:65岁及以上的患者使用机械假体替换心脏瓣膜。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND AND AIM OF THE STUDY: Recent data regarding the performance of mechanical prostheses in patients aged > or =65 years are scant. Hence, the outcome of mechanical prosthesis implantation in this age group has been retrospectively evaluated. METHODS: Between January 1990 and October 2002, 253 patients (163 males, 90 females) aged > or =65 years (mean age 68.2 years) underwent aortic valve replacement (AVR) and/or mitral valve replacement (MVR) at the authors' institution. RESULTS: Among the patients, 94 (37.2%) had MVR, 137 (54.1%) had AVR, and 22 (8.7%) had MVR+AVR. In total, 99 patients (39.1%) had concomitant coronary artery bypass grafting (CABG). The early mortality rate was 11.1%; that for patients aged > or =70 years was greater than that for patients aged 65-69 years (14.5% versus 9.6%, p <0.001). The overall actuarial survival was 91.3 +/- 2.4% at 5 years, 81.1 +/- 4.1% at 8 years, and 73.8 +/- 6.3% at 10 years. Actuarial survival for patients with isolated AVR and MVR at 10 years was 84.7 +/- 6.0% and 61.4 +/- 18.8%, respectively. Actuarial survival at 10 years for patients with isolated valve replacement was 76.1 +/- 8.1%, and 68.7 +/- 10.2% for patients with concomitant CABG (p = 0.680). Actuarial survival at 10 years was 81.3 +/- 6.9% for patients aged 65-69 years, and 50.3 +/- 11.0% for patients aged > or =70 years (p = 0.001). Freedom from a major thromboembolic event was 99.4 +/- 0.7% at five years and 86.3 +/- 6.0% at 10 years, while freedom from hemorrhage was 90.4 +/- 2.6% and 70.3 +/- 6.8%, respectively. CONCLUSION: Mechanical prostheses can be used in patients aged > or =65 years, with favorable results. However, on the basis of the present findings, patients aged > or =70 years have a reduced early and late survival.
机译:研究背景和目的:关于年龄≥65岁的患者机械假体性能的最新数据很少。因此,已经回顾性评估了该年龄段的机械假体植入的结果。方法:在1990年1月至2002年10月之间,作者年龄≥65岁(平均年龄68.2岁)的253例患者(男163例,女90例)接受了主动脉瓣置换术(AVR)和/或二尖瓣置换术(MVR)。机构。结果:在这些患者中,有94例(37.2%)患有MVR,137例(54.1%)患有AVR,而22例(8.7%)患有MVR + AVR。共有99例患者(39.1%)进行了冠状动脉搭桥术(CABG)。早期死亡率为11.1%;大于或等于70岁的患者的这一比率高于65-69岁的患者(14.5%对9.6%,p <0.001)。总体精算生存率在5年时为91.3 +/- 2.4%,在8年时为81.1 +/- 4.1%,在10年时为73.8 +/- 6.3%。孤立的AVR和MVR的10年患者的精算生存率分别为84.7 +/- 6.0%和61.4 +/- 18.8%。单纯瓣膜置换术患者10年的精算生存率为76.1 +/- 8.1%,伴有CABG的患者为68.7 +/- 10.2%(p = 0.680)。 65-69岁患者的10年精算生存率为81.3 +/- 6.9%,> 70岁或= 70岁的患者为50.3 +/- 11.0%(p = 0.001)。五年内无重大血栓栓塞事件的发生率为99.4 +/- 0.7%,十年内无出血的发生率为86.3 +/- 6.0%,而无出血的发生率分别为90.4 +/- 2.6%和70.3 +/- 6.8%。结论:机械假体可用于≥65岁的患者,效果良好。但是,根据目前的发现,年龄≥70岁的患者的早期和晚期生存期降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号